A phase 3, randomized, double-blind clinical study of pembrolizumab (MK-3475) plus chemotherapy versus placebo plus chemotherapy as first-line treatment in participants with HER2 negative, previously untreated, unresectable or metastatic gastric orgastroesophageal junction adenocarcinoma (KEYNOTE-859)
NCT ID NCT03675737
Summary
The purpose of this study is to evaluate the efficacy of pembrolizumab (MK-3745) in combination with chemotherapy (Cisplatin combined with 5-Fluorouracil \[FP regimen\] or oxaliplatin combined with capecitabine \[CAPOX regimen\]) versus placebo in combination with chemotherapy (FP or CAPOX regimens) in the treatment of human epidermal growth factor receptor 2 (HER2) negative advanced gastric or GEJ adenocarcinoma in adult participants. The primary hypotheses of this study are that pembrolizumab plus chemotherapy is superior to placebo plus chemotherapy in terms of overall survival (OS). Once a participant has achieved the study objective or the study has ended, the participant will be discontinued from this study and enrolled in an extension study (Keynote 587; NCT03486873) to continue protocol-defined assessments and treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STOMACH NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
1st Affil hosp of Med College of Xi'an Jiaotong University ( Site 2428)
XiAn, Shanxi, 710061, China
-
900 Hospital of the Joint ( Site 2418)
Fuzhou, Fujian, 350025, China
-
Aalborg University Hospital ( Site 3204)
Aalborg, North Denmark, 9000, Denmark
-
Abdurrahman Yurtaslan Onkoloji Egitim ve Arastirma Hastanesi ( Site 2006)
Ankara, 06200, Turkey (Türkiye)
-
Adana Sehir Hastanesi ( Site 2002)
Adana, 01370, Turkey (Türkiye)
-
Aichi Cancer Center Hospital ( Site 2619)
Nagoya, Aichi-ken, 464-8681, Japan
-
Allegheny General Hospital ( Site 0118)
Pittsburgh, Pennsylvania, 15212, United States
-
Asan Medical Center ( Site 2802)
Seoul, 05505, South Korea
-
Asklepios Klinik Altona ( Site 1100)
Hamburg, 22763, Germany
-
Ataturk Universitesi Tip Fakultesi Hastanesi ( Site 2000)
Erzurum, 25240, Turkey (Türkiye)
-
Auckland City Hospital ( Site 2700)
Auckland, Northland, 1023, New Zealand
-
Azienda Ospedaliera San Camillo Forlanini ( Site 1413)
Roma, 00152, Italy
-
BC Cancer - Abbotsford ( Site 0206)
Abbotsford, British Columbia, V2S 0C2, Canada
-
Bacs-Kiskun Megyei Korhaz ( Site 3306)
Kecskemét, Bács-Kiskun county, 6000, Hungary
-
Beaumont Hospital ( Site 2101)
Dublin, D09V2N0, Ireland
-
Blokhin National Medical Oncology ( Site 1604)
Moscow, Moscow, 115478, Russia
-
Box Hill Hospital ( Site 2300)
Box Hill, Victoria, 3128, Australia
-
C.H.R.U. de Brest - Hopital Morvan ( Site 1007)
Brest, Finistere, 29200, France
-
CEPON - Centro de Pesquisas Oncologicas ( Site 0400)
Florianópolis, Santa Catarina, 88034-000, Brazil
-
CHU Hopital Saint Antoine ( Site 1001)
Paris, 75012, France
-
CHU de Rouen ( Site 1006)
Rouen, Ain, 76000, France
-
CHU-Jean Minjoz ( Site 1002)
Besançon, Doubs, 25030, France
-
CIMCA Centro de Investigacion y Manejo del Cancer ( Site 3001)
San José, 10103, Costa Rica
-
CIONC - Centro Integrado de Oncologia de Curitiba ( Site 0405)
Curitiba, Paraná, 80810-050, Brazil
-
Cancer Care Langenhoven Drive Oncology Centre ( Site 1708)
Port Elizabeth, Eastern Cape, 6045, South Africa
-
Cancer Hospital Affiliated to Xinjiang Medical University ( Site 2420)
Ürümqi, Xinjiang, 830001, China
-
Cancer Hospital Chinese Academy of Medical Sciences ( Site 2421)
Beijing, Beijing Municipality, 100021, China
-
Cancer Treatment Centers of America - Philadelphia ( Site 0112)
Philadelphia, Pennsylvania, 19124, United States
-
Cancercare Rondebosch Oncology ( Site 1709)
Cape Town, Western Cape, 7700, South Africa
-
Cape Town Oncology Trials Pty Ltd ( Site 1703)
Kraaifontein, Western Cape, 7570, South Africa
-
Castle Hill Hospital ( Site 1201)
Cottingham, East Riding Of Yorkshire, HU16 5JQ, United Kingdom
-
Celan SA ( Site 0705)
Guatemala City, 01010, Guatemala
-
Central Clinical Hospital with Polyclinic ( Site 1614)
Moscow, Moscow, 121359, Russia
-
Centre Oscar Lambret ( Site 1003)
Lille, Nord, 59000, France
-
Centro Medico Imbanaco de Cali S.A ( Site 0604)
Cali, Valle del Cauca Department, 760042, Colombia
-
Centro Oncologico Riojano Integral ( Site 0313)
La Rioja, F5300COE, Argentina
-
Centro Regional de Sub Especialidades Medicas SA ( Site 0703)
Quetzaltenango, 09001, Guatemala
-
Chaim Sheba Medical Center ( Site 1304)
Ramat Gan, Tel Aviv, 5266202, Israel
-
Chang Gung Medical Foundation. Kaohsiung Branch ( Site 2902)
Kaohsiung City, 83301, Taiwan
-
Changzhou Cancer Hospital-Changzhou Fourth Peoples Hospital ( Site 2441)
Changzhou, Jiangsu, 213032, China
-
Charite Universitaetsmedizin Berlin ( Site 1101)
Berlin, 13353, Germany
-
Chelyabinsk Regional Clinical Oncology Dispensary-Chemotherapy ( Site 1608)
Chelyabinsk, Chelyabinsk Oblast, 454087, Russia
-
Christus Muguerza Clinica Vidriera ( Site 0802)
Monterrey, Nuevo León, 64570, Mexico
-
City Clinical Hosp.4 of DCC ( Site 2201)
Dnipro, Dnipropetrovsk Oblast, 49102, Ukraine
-
City Clinical Oncology Center ( Site 1603)
Saint Petersburg, Sankt-Peterburg, 198255, Russia
-
Clinic of National Cancer Institute ( Site 2203)
Kyiv, Kyivska Oblast, 03022, Ukraine
-
Clinica Ricardo Palma Instituto de Oncologia y Radioterapia ( Site 0908)
Lima, 15036, Peru
-
Clinica San Gabriel ( Site 0907)
Lima, 15088, Peru
-
Communal non profit enterprise Regional Clinical Oncology Center ( Site 2208)
Kharkiv, Kharkivs’ka Oblast’, 61070, Ukraine
-
Dokuz Eylul Universitesi Tip Fakultesi Hastanesi ( Site 2011)
Izmir, 35340, Turkey (Türkiye)
-
Dolnoslaskie Centrum Onkologii we Wroclawiu ( Site 1504)
Wroclaw, Lower Silesian Voivodeship, 53-413, Poland
-
Edith Wolfson Medical Center ( Site 1307)
Holon, Tell Abib, 5822012, Israel
-
FN Ostrava ( Site 3105)
Ostrava, Moravskoslezský kraj, 708 52, Czechia
-
Facharztzentrum Eppendorf ( Site 1121)
Hamburg, 20249, Germany
-
Fakultni Thomayerova nemocnice ( Site 3101)
Prague, 140 59, Czechia
-
Fakultni nemocnice Olomouc ( Site 3100)
Olomouc, 779 00, Czechia
-
Fakultni nemocnice Plzen ( Site 3102)
Pilsen, Plzeň Region, 304 60, Czechia
-
Fourth Hospital Of Hebei Medical University ( Site 2436)
Shijiazhuang, Hebei, 050011, China
-
Fujian Medical University Union Hospital ( Site 2410)
Fuzhou, Fujian, 350001, China
-
Fujian Provincial Cancer Hospital ( Site 2414)
Fuzhou, Fujian, 350014, China
-
Fundacion Arturo Lopez Perez FALP ( Site 0501)
Santiago, Region M. de Santiago, 7500921, Chile
-
Fundacion Favaloro - Hospital Universitario ( Site 0302)
Buenos Aires, C1093AAS, Argentina
-
Greater Baltimore Medical Center ( Site 0102)
Baltimore, Maryland, 21204, United States
-
Groote Schuur Hospital ( Site 1706)
Cape Town, Western Cape, 7925, South Africa
-
Grupo Angeles SA ( Site 0701)
Guatemala City, 01015, Guatemala
-
Guangdong General Hospital ( Site 2431)
Guangzhou, Guangdong, 510080, China
-
HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID-ONCOLOGIA MEDICA ( Site 1805)
Pozuelo de Alarcón, Madrid, 28223, Spain
-
Hacettepe University Medical Faculty ( Site 2017)
Ankara, 06100, Turkey (Türkiye)
-
Hadassah Ein Karem Jerusalem ( Site 1301)
Jerusalem, Jerusalem, 9112001, Israel
-
Harbin Medical University Cancer Hospital ( Site 2401)
Harbin, Heilongjiang, 150081, China
-
Henan Cancer Hospital ( Site 2415)
Zhengzhou, Henan, 450008, China
-
Hiroshima City Hiroshima Citizens Hospital ( Site 2611)
Hiroshima, 730-8518, Japan
-
Hopitaux Universitaires de Geneve HUG ( Site 1907)
Geneva, Canton of Geneva, 1211, Switzerland
-
Hospital Civil de Guadalajara Fray Antonio Alcalde ( Site 0808)
Guadalajara, Jalisco, 44280, Mexico
-
Hospital General Universitari Vall d Hebron ( Site 1801)
Barcelona, 08035, Spain
-
Hospital General Universitario de Elche ( Site 1803)
Elche, Alicante, 03203, Spain
-
Hospital Nacional Arzobispo Loayza ( Site 0902)
Lima, 15082, Peru
-
Hospital Nossa Senhora da Conceicao ( Site 0403)
Porto Alegre, Rio Grande do Sul, 91350-200, Brazil
-
Hospital Universitario General de Asturias ( Site 1802)
Oviedo, Principality of Asturias, 33011, Spain
-
Hospital Universitario Marques de Valdecilla ( Site 1804)
Santander, Cantabria, 39008, Spain
-
Hospital de Caridade de Ijui ( Site 0402)
Ijuí, Rio Grande do Sul, 98700 000, Brazil
-
Hubei Cancer Hospital ( Site 2434)
Wuhan, Hubei, 430079, China
-
Hunan Cancer Hospital ( Site 2439)
Changsha, Hunan, 410013, China
-
Hyogo Cancer Center ( Site 2604)
Akashi, Hyōgo, 673-8558, Japan
-
IBCC - Instituto Brasileiro de Controle do Cancer ( Site 0404)
São Paulo, 03102-002, Brazil
-
ICIMED - Instituto de Investigacion en Ciencias Medicas ( Site 3000)
San José, 10108, Costa Rica
-
Ibaraki Prefectural Central Hospital ( Site 2610)
Kasama, Ibaraki, 309-1793, Japan
-
Institut Catala d Oncologia Hospital Germans Trias i Pujol ( Site 1806)
Badalona, Barcelona, 08916, Spain
-
Institut Gustave Roussy ( Site 1000)
Villejuif, Val-de-Marne, 94805, France
-
Institut de Cancerologie de l Ouest Centre Rene Gauducheau ( Site 1004)
Saint-Herblain, Val-de-Marne, 44805, France
-
Instituto Clinico Oncologico del Sur ( Site 0500)
Temuco, Región de la Araucanía, 4810469, Chile
-
Instituto Medico Alexander Fleming ( Site 0307)
Buenos Aires, Buenos Aires F.D., C1426ANZ, Argentina
-
Instituto Nacional de Cancerologia E.S.E ( Site 0605)
Bogotá, Bogota D.C., 110321, Colombia
-
Instituto Nacional de Cancerologia. ( Site 0804)
Mexico City, 14080, Mexico
-
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( Site 0806)
Mexico City, 14080, Mexico
-
Instituto Nacional de Enfermedades Neoplasicas ( Site 0901)
Lima, 15038, Peru
-
Instituto Nacional do Cancer Jose Alencar Gomes da Silva INCA ( Site 0401)
Rio de Janeiro, 20231-050, Brazil
-
Instituto San Marcos ( Site 0311)
San Juan, J5400EBB, Argentina
-
Instituto de Investigaciones Metabolicas ( Site 0312)
Buenos Aires, C1012AAR, Argentina
-
Instituto do Cancer do Ceara ( Site 0407)
Fortaleza, Ceará, 60430-230, Brazil
-
Istanbul Universitesi Cerrahpasa Tip Fakultesi ( Site 2001)
Istanbul, 34098, Turkey (Türkiye)
-
Istituto Europeo di Oncologia ( Site 1411)
Milan, Lombardy, 20141, Italy
-
Istituto Nazionale dei Tumori Fondazione IRCSS ( Site 1402)
Milan, 20133, Italy
-
Istituto Oncologica della Svizzera Italiana (IOSI) ( Site 1905)
Bellinzona, Canton Ticino, 6500, Switzerland
-
Istituto Oncologico Veneto ( Site 1412)
Padua, 35128, Italy
-
Jasz-Nagykun-Szolnok Megyei Hetenyi Gyula Korhaz-Rendelointezet ( Site 3302)
Szolnok, Jász-Nagykun-Szolnok, 5004, Hungary
-
Jiangsu Cancer Hospital ( Site 2432)
Nanjing, Jiangsu, 210009, China
-
Kagawa University Hospital ( Site 2615)
Kita-gun, Kagawa-ken, 761-0793, Japan
-
Kanagawa Cancer Center ( Site 2614)
Yokohama, Kanagawa, 241-8515, Japan
-
Kansai Medical University Hospital ( Site 2608)
Hirakata, Osaka, 573-1191, Japan
-
Kantonsspital Graubuenden ( Site 1903)
Chur, Kanton Graubünden, 7000, Switzerland
-
Kantonsspital St. Gallen ( Site 1901)
Sankt Gallen, Canton of St. Gallen, 9007, Switzerland
-
Kindai University Hospital ( Site 2616)
Sayama, Osaka, 589-8511, Japan
-
Kitasato University Hospital ( Site 2618)
Sagamihara, Kanagawa, 252-0375, Japan
-
Kobe City Medical Center General Hospital ( Site 2603)
Kobe, Hyōgo, 650-0047, Japan
-
Kumamoto University Hospital ( Site 2602)
Kumamoto, 860-8556, Japan
-
Kyiv City Clinical Oncology Centre ( Site 2213)
Kyiv, 03115, Ukraine
-
Liverpool Hospital ( Site 2301)
Liverpool, New South Wales, 2170, Australia
-
Luzern Kantonsspital ( Site 1904)
Lucerne, 6000, Switzerland
-
Lviv State Oncology Regional Treatment and Diagnostic Center ( Site 2210)
Lviv, Lviv Oblast, 79031, Ukraine
-
MEDI-K CAYALA ( Site 0704)
Guatemala City, 01016, Guatemala
-
MI Kryviy Rih Center of Dnipropetrovsk Regional Council ( Site 2200)
Kryviy Rih, Dnipropetrovsk Oblast, 50048, Ukraine
-
MI Odessa Regional Oncological Centre ( Site 2212)
Odesa, Odesa Oblast, 65055, Ukraine
-
MI Precarpathian Clinical Oncology Center ( Site 2204)
Ivano-Frankivsk, Ivano-Frankivsk Oblast, 76018, Ukraine
-
Mackay Memorial Hospital ( Site 2903)
Taipei, 104, Taiwan
-
Magodent Szpital Elblaska ( Site 1509)
Warsaw, Masovian Voivodeship, 01-748, Poland
-
Malatya Inonu Universitesi Tip Fakultesi Hastanesi ( Site 2009)
Malatya, 44280, Turkey (Türkiye)
-
Masarykuv onkologicky ustav ( Site 3103)
Brno, South Moravian, 65653, Czechia
-
McGill University Health Centre ( Site 0208)
Montreal, Quebec, H4A 3J1, Canada
-
Medical Care and Research S.A. de C.V. ( Site 0809)
Mérida, 97070, Mexico
-
Medical Centre LLC Oncolife ( Site 2202)
Zaporizhzhya, Zaporizhzhia Oblast, 69104, Ukraine
-
Medical and Diagnostic Centre LLC Dobryi Prognoz ( Site 2205)
Kyiv, Kyivska Oblast, 03126, Ukraine
-
Meir Medical Center ( Site 1308)
Kfar Saba, 4428164, Israel
-
Minnesota Oncology Hematology, PA ( Site 8000)
Minneapolis, Minnesota, 55404, United States
-
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (
Warsaw, Masovian Voivodeship, 02-781, Poland
-
National Cancer Center Hospital ( Site 2606)
Tokyo, 104-0045, Japan
-
National Cancer Center Hospital East ( Site 2617)
Kashiwa, Chiba, 277-8577, Japan
-
National Cheng Kung University Hospital ( Site 2901)
Tainan, 70457, Taiwan
-
National Hospital Organization Kyushu Cancer Center ( Site 2612)
Fukuoka, 811-1395, Japan
-
National Taiwan University Hospital ( Site 2900)
Taipei, 100225, Taiwan
-
Nemocnice AGEL Novy Jicin a.s. ( Site 3104)
Nový Jičín, 74101, Czechia
-
Niigata Cancer Center Hospital ( Site 2613)
Niigata, 951-8566, Japan
-
Odense Universitets Hospital ( Site 3201)
Odense, Region Syddanmark, 5000, Denmark
-
Oncology & Hematology Assoc. SW Virginia, Inc., DBA Blue Ridge Cancer Care ( Site 8001)
Roanoke, Virginia, 24014, United States
-
Oncomedica ( Site 0702)
Guatemala City, 01010, Guatemala
-
Oncomedica S.A. ( Site 0606)
Montería, Departamento de Córdoba, 230002, Colombia
-
Orszagos Onkologiai Intezet ( Site 3303)
Budapest, 1122, Hungary
-
Osaka International Cancer Institute ( Site 2607)
Osaka, 541-8567, Japan
-
Osaka University Hospital ( Site 2600)
Suita, Osaka, 565-0871, Japan
-
Outeniqua Cancercare Oncology Unit ( Site 1704)
George, Western Cape, 6530, South Africa
-
Peking Union Medical College Hospital ( Site 2425)
Beijing, Beijing Municipality, 100730, China
-
Peking University Shenzhen Hospital ( Site 2442)
Shenzhen, Guangdong, 518036, China
-
Policlinico San Bosco ( Site 3002)
San José, 10103, Costa Rica
-
Pontificia Universidad Catolica de Chile ( Site 0502)
Santiago, Region M. de Santiago, 7620002, Chile
-
Prince of Wales Hospital ( Site 2503)
Hong Kong, Hong Kong
-
Princess Margaret Cancer Centre ( Site 0203)
Toronto, Ontario, M5G 2M9, Canada
-
Princess Margaret Hospital. ( Site 2502)
Hong Kong, Hong Kong
-
Przychodnia Lekarska Komed ( Site 1514)
Konin, Greater Poland Voivodeship, 62-500, Poland
-
Queen Mary Hospital ( Site 2501)
Hong Kong, Hong Kong
-
Rabin Medical Center ( Site 1302)
Petah Tikva, 4941492, Israel
-
Rambam Medical Center ( Site 1303)
Haifa, 3109601, Israel
-
Regionalny Szpital Specjalistyczny im Wl. Bieganskiego w Grudziadzu ( Site 1505)
Grudziądz, 86-300, Poland
-
Rigshospitalet ( Site 3202)
Copenhagen, Capital Region, 2100, Denmark
-
SBHI Leningrad Regional Clinical Hospital ( Site 1616)
Saint Petersburg, Leningradskaya Oblast', 194291, Russia
-
SBHI Samara Regional Clinical Oncology Dispensary ( Site 1609)
Samara, Samara Oblast, 443031, Russia
-
SLK-Kliniken Heilbronn ( Site 1104)
Heilbronn, Baden-Wurttemberg, 74078, Germany
-
Saitama Cancer Center ( Site 2601)
Kitaadachi-gun, Saitama, 362-0806, Japan
-
Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012)
Sakarya, 54000, Turkey (Türkiye)
-
Samsung Medical Center ( Site 2801)
Seoul, 06351, South Korea
-
Sandton Oncology Medical Group PTY LTD ( Site 1700)
Johannesburg, Gauteng, 2196, South Africa
-
Semmelweis Egyetem.. ( Site 3305)
Budapest, 1083, Hungary
-
Seoul National University Hospital ( Site 2803)
Seoul, 03080, South Korea
-
Severance Hospital Yonsei University Health System ( Site 2800)
Seoul, 03722, South Korea
-
Shanghai East Hospital ( Site 2403)
Shanghai, Shanghai Municipality, 200120, China
-
Sir Run Run Show Hospital ( Site 2427)
Hangzhou, Zhejiang, 310016, China
-
Sociedad Oncovida S.A. ( Site 0508)
Santiago, Region M. de Santiago, 7510032, Chile
-
Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 0608)
Valledupar, Cesar Department, 200001, Colombia
-
Soroka University Medical Center ( Site 1305)
Beersheba, 8410101, Israel
-
Sourasky Medical Center ( Site 1306)
Tel Aviv, Tell Abib, 6423906, Israel
-
South Devon Healthcare Foundation Trust. Torbay Hospital ( Site 1205)
Torquay, Devon, TQ2 7AA, United Kingdom
-
Southern Medical Day Care Centre ( Site 2303)
Wollongong, New South Wales, 2500, Australia
-
St. Georges University Hospital NHS Foundation Trust ( Site 1204)
London, London, City of, SW17 0QT, United Kingdom
-
St. James s Hospital ( Site 1200)
Dublin, D08 W9RT, Ireland
-
Sunnybrook Research Institute ( Site 0202)
Toronto, Ontario, M4N 3M5, Canada
-
Szpital Uniwersytecki w Krakowie ( Site 1503)
Krakow, Lesser Poland Voivodeship, 31-501, Poland
-
Tallaght University Hospital ( Site 1202)
Dublin, D24 NR0A, Ireland
-
The 81st Hospital of PLA ( Site 2413)
Nanjing, Jiangsu, 210002, China
-
The Affiliated Hospital of Qingdao University ( Site 2405)
Qingdao, Shandong, 266061, China
-
The Cancer Institute Hospital of JFCR ( Site 2609)
Tokyo, 135-8550, Japan
-
The First Affiliated Hospital of Nanchang University ( Site 2440)
Nanchang, Jiangxi, 330006, China
-
The First Affiliated Hospital of Xiamen University ( Site 2430)
Xiamen, Fujian, 361003, China
-
The First Hospital of Jilin University ( Site 2416)
Changchun, Jilin, 130021, China
-
The Oncology Centre Overport and Umhlanga ( Site 1705)
Durban, KwaZulu-Natal, 4091, South Africa
-
Tokyo Metropolitan Komagome Hospital ( Site 2605)
Tokyo, 113-8677, Japan
-
Trakya Universitesi Tip Fakultesi ( Site 2015)
Edirne, 22030, Turkey (Türkiye)
-
Tshwane District Hospital ( Site 1702)
Pretoria, Gauteng, 0002, South Africa
-
UC Irvine Health/Division of Hematology Oncology, Dept of Medicine ( Site 0128)
Orange, California, 92868, United States
-
UCLA Hematology/Oncology - Westwood (Building 200 Suite 120) ( Site 0124)
Los Angeles, California, 90095, United States
-
Universitaetsklinikum Leipzig ( Site 1114)
Leipzig, Saxony, 04103, Germany
-
Universitaetsspital Basel ( Site 1900)
Basel, Canton of Basel-City, 4056, Switzerland
-
Universitaetsspital Zuerich ( Site 1902)
Zurich, Canton of Zurich, 8091, Switzerland
-
Universitas Annex National Hospital ( Site 1701)
Bloemfontein, Free State, 9301, South Africa
-
University College London Hospital ( Site 1211)
London, London, City of, NW1 2PG, United Kingdom
-
University of Debrecen Medical Center Clinic of Oncology ( Site 3300)
Debrecen, 4032, Hungary
-
University of Miami, Sylvester Comprehensive Cancer Center ( Site 0113)
Miami, Florida, 33136, United States
-
University of Rochester ( Site 0122)
Rochester, New York, 14642, United States
-
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego ( Site 1506)
Wroclaw, Lower Silesian Voivodeship, 50-556, Poland
-
Wenatchee Valley Clinic [Wenatchee, WA] ( Site 0116)
Wenatchee, Washington, 98801, United States
-
Wits Clinical Research ( Site 1707)
Parktown-Johannesburg, Gauteng, 2193, South Africa
-
Xiangya Hospital Central-South University ( Site 2419)
Changsha, Hunan, 410008, China
-
Yancheng First People s Hospital ( Site 2426)
Yancheng, Jiangsu, 224000, China
-
Zhejiang Cancer Hospital ( Site 2417)
Hangzhou, Zhejiang, 310022, China
-
Zhejiang Provincial People's Hospital ( Site 2446)
Hangzhou, Zhejiang, 310014, China
-
Zhongshan Hospital Xiamen University ( Site 2447)
Xiamen, Fujian, 361004, China
-
Zhongshan Hospital affiliated to Fudan University ( Site 2407)
Shanghai, Shanghai Municipality, 210000, China
Conditions
Explore the condition pages connected to this study.